Aptose Biosciences
APTO
#10377
Rank
โ‚ฌ3.77 M
Marketcap
1,48ย โ‚ฌ
Share price
0.00%
Change (1 day)
-46.25%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -โ‚ฌ19.25 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ21.8 Million, an increase over its 2023 earnings that were of -โ‚ฌ45.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ19.25 Million-11.68%
2024 -โ‚ฌ21.8 Million-51.82%
2023 -โ‚ฌ45.25 Million22.9%
2022 -โ‚ฌ36.82 Million-34.91%
2021 -โ‚ฌ56.56 Million17.36%
2020 -โ‚ฌ48.19 Million107.65%
2019 -โ‚ฌ23.21 Million-7.73%
2018 -โ‚ฌ25.16 Million160.68%
2017 -โ‚ฌ9.65 Million-20.27%
2016 -โ‚ฌ12.11 Million28.71%
2015 -โ‚ฌ9.41 Million
2013 -โ‚ฌ5.33 Million
2010 -โ‚ฌ4.54 Million-8.31%
2009 -โ‚ฌ4.96 Million
2006 -โ‚ฌ9.18 Million-156.93%
2005 โ‚ฌ16.12 M-185.16%
2004 -โ‚ฌ18.94 Million458.58%
2003 -โ‚ฌ3.39 Million-63.66%
2002 -โ‚ฌ9.33 Million-8.04%
2001 -โ‚ฌ10.15 Million16.73%
2000 -โ‚ฌ8.69 Million294.99%
1999 -โ‚ฌ2.2 Million-6.51%
1998 -โ‚ฌ2.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ImmunoGen
IMGN
-โ‚ฌ54.25 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-โ‚ฌ58.34 Million 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-โ‚ฌ29.4 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA